Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 517

1.

[A Case of Castleman's Disease with Lymphadenopathy during the Treatment of Gastric Cancer].

Shimura Y, Hirao T, Hara S, Takayama K, Teranishi R, Ohashi T, Osawa H, Sakai K, Yasumasa K, Noro H, Iwasaki T, Nishioka Y, Hatanaka N, Yamasaki Y.

Gan To Kagaku Ryoho. 2019 Apr;46(4):739-741. Japanese.

PMID:
31164520
2.

Paclitaxel for relapsed small-cell lung cancer patients with idiopathic interstitial pneumonias.

Saijo A, Hanibuchi M, Ogino H, Otsuka K, Goto H, Nokihara H, Nishioka Y.

Mol Clin Oncol. 2019 May;10(5):541-546. doi: 10.3892/mco.2019.1828. Epub 2019 Mar 19.

3.

A rare resected case of pulmonary rhabdomyosarcoma.

Nishioka Y, Tane S, Nishio W, Tanaka H, Ogawa H, Kitamura Y, Sakuma T, Yoshimura M.

Gen Thorac Cardiovasc Surg. 2019 Feb 26. doi: 10.1007/s11748-019-01086-7. [Epub ahead of print]

PMID:
30806970
4.

Expanded Makuuchi's criteria using estimated indocyanine green clearance rate of future liver remnant as a safety limit for maximum extent of liver resection.

Kobayashi Y, Kiya Y, Sugawara T, Nishioka Y, Hashimoto M, Shindoh J.

HPB (Oxford). 2019 Jan 30. pii: S1365-182X(19)30001-2. doi: 10.1016/j.hpb.2018.12.001. [Epub ahead of print]

PMID:
30711244
5.

Stent placement for benign portal vein stenosis following pancreaticoduodenectomy in a hybrid operating room.

Sawai Y, Kokudo T, Sakamoto Y, Takao H, Kazami Y, Nishioka Y, Akamatsu N, Arita J, Kaneko J, Hasegawa K.

Biosci Trends. 2019 Jan 22;12(6):641-644. doi: 10.5582/bst.2018.01296. Epub 2018 Dec 28.

6.

Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice.

Kishi M, Aono Y, Sato S, Koyama K, Azuma M, Abe S, Kawano H, Kishi J, Toyoda Y, Okazaki H, Ogawa H, Uehara H, Nishioka Y.

PLoS One. 2018 Dec 31;13(12):e0209786. doi: 10.1371/journal.pone.0209786. eCollection 2018.

7.

Variation in fracture risk by season and weather: A comprehensive analysis across age and fracture site using a National Database of Health Insurance Claims in Japan.

Hayashi S, Noda T, Kubo S, Myojin T, Nishioka Y, Higashino T, Imamura T.

Bone. 2019 Mar;120:512-518. doi: 10.1016/j.bone.2018.12.014. Epub 2018 Dec 18.

PMID:
30576867
8.

[Evaluation of supplemental and oral deglutition foods in bedridden elderly patients receiving parenteral nutrition].

Nishioka Y, Miyake E, Hayashi S, Kikuthi N, Nakamura K.

Nihon Ronen Igakkai Zasshi. 2018;55(4):594-604. doi: 10.3143/geriatrics.55.594. Japanese.

9.

The Tyrosine Kinase Inhibitor TAS-115 Attenuates Bleomycin-induced Lung Fibrosis in Mice.

Koyama K, Goto H, Morizumi S, Kagawa K, Nishimura H, Sato S, Kawano H, Toyoda Y, Ogawa H, Homma S, Nishioka Y.

Am J Respir Cell Mol Biol. 2019 Apr;60(4):478-487. doi: 10.1165/rcmb.2018-0098OC.

PMID:
30540913
10.

Systemic Sarcoidosis Presenting with Renal Involvement Caused by Various Sarcoidosis-associated Pathophysiological Conditions.

Ueda S, Murakami T, Ogino H, Matsuura M, Tamaki M, Kishi S, Hann M, Toyoda Y, Nagai K, Bando Y, Abe H, Nishioka Y, Doi T.

Intern Med. 2019 Mar 1;58(5):679-684. doi: 10.2169/internalmedicine.1558-18. Epub 2018 Nov 19.

11.

The clinical features of older patients with lung cancer in comparison with their younger counterparts.

Ogino H, Hanibuchi M, Sakaguchi S, Toyoda Y, Tezuka T, Kawano H, Kakiuchi S, Otsuka K, Saijo A, Azuma M, Nokihara H, Goto H, Nishioka Y.

Respir Investig. 2019 Jan;57(1):40-48. doi: 10.1016/j.resinv.2018.10.003. Epub 2018 Nov 15.

PMID:
30448243
12.

A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.

Hanibuchi M, Kakiuchi S, Atagi S, Ogushi F, Shimizu E, Haku T, Toyoda Y, Azuma M, Kondo M, Kawano H, Otsuka K, Sakaguchi S, Nokihara H, Goto H, Nishioka Y.

Lung Cancer. 2018 Nov;125:93-99. doi: 10.1016/j.lungcan.2018.09.007. Epub 2018 Sep 12.

PMID:
30429044
13.

Effect of Janus kinase inhibition by tofacitinib on body composition and glucose metabolism.

Chikugo M, Sebe M, Tsutsumi R, Iuchi M, KIshi J, Kuroda M, Harada N, Nishioka Y, Sakaue H.

J Med Invest. 2018;65(3.4):166-170. doi: 10.2152/jmi.65.166.

14.

Detection of Autoreactive Type II NKT Cells: A Pilot Study of Comparison Between Healthy Individuals and Patients with Vasculitis.

Nishioka Y, Sonoda T, Shida H, Kusunoki Y, Hattanda F, Tanimura S, Uozumi R, Yamada M, Nishibata Y, Masuda S, Nakazawa D, Tomaru U, Atsumi T, Ishizu A.

Cytometry A. 2018 Nov;93(11):1157-1164. doi: 10.1002/cyto.a.23618. Epub 2018 Sep 25.

PMID:
30253046
15.

Neutrophils induce smooth muscle hyperplasia via neutrophil elastase-induced FGF-2 in a mouse model of asthma with mixed inflammation.

Ogawa H, Azuma M, Tsunematsu T, Morimoto Y, Kondo M, Tezuka T, Nishioka Y, Tsuneyama K.

Clin Exp Allergy. 2018 Dec;48(12):1715-1725. doi: 10.1111/cea.13263. Epub 2018 Sep 24.

PMID:
30171733
16.

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial.

Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Blahova Z, Wachtlin D, Diefenbach C, Jenkins RG.

BMJ Open Respir Res. 2018 Aug 20;5(1):e000325. doi: 10.1136/bmjresp-2018-000325. eCollection 2018.

17.

A case of pulmonary pleomorphic carcinoma with malignant phenotypes induced by ZEB1-associated epithelial-mesenchymal transition.

Kondo M, Ogino H, Ogawa H, Afroj T, Toyoda Y, Sakaguchi S, Tsuboi M, Bando Y, Goto H, Tsuneyama K, Nishioka Y.

Respir Med Case Rep. 2018 Aug 3;25:119-121. doi: 10.1016/j.rmcr.2018.07.008. eCollection 2018.

18.

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC.

Arasada RR, Shilo K, Yamada T, Zhang J, Yano S, Ghanem R, Wang W, Takeuchi S, Fukuda K, Katakami N, Tomii K, Ogushi F, Nishioka Y, Talabere T, Misra S, Duan W, Fadda P, Rahman MA, Nana-Sinkam P, Evans J, Amann J, Tchekneva EE, Dikov MM, Carbone DP.

Nat Commun. 2018 Aug 10;9(1):3198. doi: 10.1038/s41467-018-05626-2.

19.

Japanese guideline for the treatment of idiopathic pulmonary fibrosis.

Homma S, Bando M, Azuma A, Sakamoto S, Sugino K, Ishii Y, Izumi S, Inase N, Inoue Y, Ebina M, Ogura T, Kishi K, Kishaba T, Kido T, Gemma A, Goto Y, Sasaki S, Johkoh T, Suda T, Takahashi K, Takahashi H, Taguchi Y, Date H, Taniguchi H, Nakayama T, Nishioka Y, Hasegawa Y, Hattori N, Fukuoka J, Miyamoto A, Mukae H, Yokoyama A, Yoshino I, Watanabe K; Ministry of Health, Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases, and Japanese Respiratory Society.

Respir Investig. 2018 Jul;56(4):268-291. doi: 10.1016/j.resinv.2018.03.003. Epub 2018 Jul 3. Review.

PMID:
29980444
20.

Host MICA Polymorphism as a Potential Predictive Marker in Response to Chemotherapy for Colorectal Liver Metastases.

Nishioka Y, Shindoh J, Inagaki Y, Gonoi W, Mitsui J, Abe H, Yoshioka R, Yoshida S, Fukayama M, Tsuji S, Hashimoto M, Hasegawa K, Kokudo N.

Dig Dis. 2018;36(6):437-445. doi: 10.1159/000490411. Epub 2018 Jul 3.

PMID:
29969766
21.

Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.

Itai S, Ohishi T, Kaneko MK, Yamada S, Abe S, Nakamura T, Yanaka M, Chang YW, Ohba SI, Nishioka Y, Kawada M, Harada H, Kato Y.

Oncotarget. 2018 Apr 27;9(32):22480-22497. doi: 10.18632/oncotarget.25132. eCollection 2018 Apr 27.

22.

Possibility of Interstitial Lung Disease as a Phlebosclerotic Colitis Manifestation.

Takemura T, Kataoka Y, Iki R, Nishioka Y, Matsubara N, Kanagaki M, Yasumizu Y.

Case Rep Gastroenterol. 2018 Apr 24;12(1):182-188. doi: 10.1159/000488525. eCollection 2018 Jan-Apr.

23.

Thymidine catabolism promotes NADPH oxidase-derived reactive oxygen species (ROS) signalling in KB and yumoto cells.

Tabata S, Yamamoto M, Goto H, Hirayama A, Ohishi M, Kuramoto T, Mitsuhashi A, Ikeda R, Haraguchi M, Kawahara K, Shinsato Y, Minami K, Saijo A, Toyoda Y, Hanibuchi M, Nishioka Y, Sone S, Esumi H, Tomita M, Soga T, Furukawa T, Akiyama SI.

Sci Rep. 2018 Apr 30;8(1):6760. doi: 10.1038/s41598-018-25189-y.

24.

[A Case of HER2 Positive Occult Breast Cancer Presenting as Swollen Axillary Lymph Nodes].

Ishiba T, Oda G, Nakagawa T, Akashi T, Yamashita Y, Aburatani T, Ogo T, Nakashima Y, Baba H, Hoshino N, Nishioka Y, Kawano T.

Gan To Kagaku Ryoho. 2018 Mar;45(3):533-535. Japanese.

PMID:
29650929
25.

[Gallbladder Carcinoma That Occurred 50 Years after Cholecystojejunostomy].

Kubota M, Hashimoto Y, Imamura H, Yagi Y, Noma T, Mokutani Y, Nagai K, Hirose H, Ide Y, Matsuyama J, Fukushima Y, Nishioka Y, Takeda M, Tamura S, Sasaki Y.

Gan To Kagaku Ryoho. 2018 Mar;45(3):513-514. Japanese.

PMID:
29650922
26.

[Hepatocellular Carcinoma with Bile Duct Thrombosis - A Case Report].

Kubota M, Hashimoto Y, Imamura H, Yagi Y, Noma T, Mokutani Y, Nagai K, Hirose H, Ide Y, Matsuyama J, Fukushima Y, Nishioka Y, Takeda M, Tamura S, Sasaki Y.

Gan To Kagaku Ryoho. 2018 Mar;45(3):501-503. Japanese.

PMID:
29650918
27.

MRI Detection of Intratumoral Fat in Colorectal Liver Metastases After Preoperative Chemotherapy.

Nakai Y, Gonoi W, Hagiwara A, Nishioka Y, Abe H, Shindoh J, Hasegawa K.

AJR Am J Roentgenol. 2018 May;210(5):W196-W204. doi: 10.2214/AJR.17.18814. Epub 2018 Apr 9.

PMID:
29629795
28.

CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.

Nishioka Y, Masuda S, Tomaru U, Ishizu A.

Front Immunol. 2018 Mar 15;9:548. doi: 10.3389/fimmu.2018.00548. eCollection 2018. Review.

29.

A case of interstitial pneumonia associated with anti-PL-7 antibody in a patient with rheumatoid arthritis.

Kozai H, Toyoda Y, Goto H, Kishi J, Tobiume M, Yamashita Y, Nishimura H, Kondo M, Kawano H, Nishioka Y.

J Med Invest. 2018;65(1.2):147-150. doi: 10.2152/jmi.65.147.

30.

Brain-derived neurotrophic factor induces angiogenin secretion and nuclear translocation in human umbilical vein endothelial cells.

Mori A, Nishioka Y, Yamada M, Nishibata Y, Masuda S, Tomaru U, Honma N, Moriyama T, Ishizu A.

Pathol Res Pract. 2018 Apr;214(4):521-526. doi: 10.1016/j.prp.2018.02.013. Epub 2018 Feb 21.

31.

Postoperative low hepatitis C virus load predicts long-term outcomes after hepatectomy for hepatocellular carcinoma.

Sasaki K, Shindoh J, Nishioka Y, Sugawara T, Margonis GA, Andreatos N, Pawlik TM, Hashimoto M.

J Surg Oncol. 2018 Apr;117(5):902-911. doi: 10.1002/jso.25015. Epub 2018 Feb 23.

PMID:
29473962
32.

Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells.

Saijo A, Goto H, Nakano M, Mitsuhashi A, Aono Y, Hanibuchi M, Ogawa H, Uehara H, Kondo K, Nishioka Y.

Cancer Lett. 2018 May 1;421:17-27. doi: 10.1016/j.canlet.2018.02.016. Epub 2018 Feb 12.

PMID:
29448000
33.

Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study.

Ozaki Y, Shindoh J, Gonoi W, Nishioka Y, Kondoh C, Tanabe Y, Matoba S, Kuroyanagi H, Hashimoto M, Takano T.

BMC Cancer. 2018 Feb 5;18(1):138. doi: 10.1186/s12885-018-4067-5.

34.

[A Case of Noninvasive Ductal Carcinoma of the Breast in a Male].

Yamashita Y, Ishiba T, Oda G, Nakagawa T, Aburatani T, Ogo T, Nakashima Y, Baba H, Hoshino N, Nishioka Y, Kawano T, Itoh T, Kirimura S, Kobayashi H.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1835-1837. Review. Japanese.

PMID:
29394792
35.

Potential Interference of Oil Vehicles on Genital Tubercle Development during the Fetal Period in ICR Mice.

Nishioka Y, Tamai K, Onda M, Hiromori Y, Kimura T, Hu J, Nagase H, Nakanishi T.

Biol Pharm Bull. 2018;41(2):266-271. doi: 10.1248/bpb.b17-00830.

36.

Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer.

Goto H, Okano Y, Machida H, Hatakeyama N, Ogushi F, Haku T, Kanematsu T, Urata T, Kakiuchi S, Hanibuchi M, Sone S, Nishioka Y.

Respir Investig. 2018 Jan;56(1):80-86. doi: 10.1016/j.resinv.2017.09.003. Epub 2017 Oct 21.

PMID:
29325686
37.

Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression.

Goto H, Nishioka Y.

Int J Mol Sci. 2017 Dec 29;19(1). pii: E98. doi: 10.3390/ijms19010098. Review.

38.

IgA Nephropathy after Nivolumab Therapy for Postoperative Recurrence of Lung Squamous Cell Carcinoma.

Kishi S, Minato M, Saijo A, Murakami N, Tamaki M, Matsuura M, Murakami T, Nagai K, Abe H, Nishioka Y, Doi T.

Intern Med. 2018 May 1;57(9):1259-1263. doi: 10.2169/internalmedicine.9814-17. Epub 2017 Dec 27.

39.

Total bilirubin amount in drainage fluid can be an early predictor for severe biliary fistula after hepatobiliary surgery.

Sugawara T, Shindoh J, Nishioka Y, Hashimoto M.

Biosci Trends. 2017 Nov 20;11(5):588-594. doi: 10.5582/bst.2017.01208. Epub 2017 Oct 24.

40.
41.

Mycobacterium wolinskyi Peritonitis after Peritoneal Catheter Embedment Surgery.

Fujikura H, Kasahara K, Ogawa Y, Hirai N, Yoshii S, Yoshihara S, Ogawa T, Yonekawa S, Imakita N, Nishioka Y, Yoneda T, Yoshida K, Samejima KI, Tanabe K, Saito Y, Yano H, Mikasa K.

Intern Med. 2017 Nov 15;56(22):3097-3101. doi: 10.2169/internalmedicine.8871-17. Epub 2017 Sep 25.

42.

Paradoxical development of polymyositis-like autoimmunity through augmented expression of autoimmune regulator (AIRE).

Nishijima H, Kajimoto T, Matsuoka Y, Mouri Y, Morimoto J, Matsumoto M, Kawano H, Nishioka Y, Uehara H, Izumi K, Tsuneyama K, Okazaki IM, Okazaki T, Hosomichi K, Shiraki A, Shibutani M, Mitsumori K, Matsumoto M.

J Autoimmun. 2018 Jan;86:75-92. doi: 10.1016/j.jaut.2017.09.006. Epub 2017 Sep 18.

43.

Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity.

Sato S, Shinohara S, Hayashi S, Morizumi S, Abe S, Okazaki H, Chen Y, Goto H, Aono Y, Ogawa H, Koyama K, Nishimura H, Kawano H, Toyoda Y, Uehara H, Nishioka Y.

Respir Res. 2017 Sep 15;18(1):172. doi: 10.1186/s12931-017-0654-2.

44.

[III. Immune Checkpoint Inhibitor as a Standard Treatment against Lung Cancer].

Otsuka K, Nishioka Y.

Gan To Kagaku Ryoho. 2017 Aug;44(8):655-660. Japanese. No abstract available.

PMID:
28860436
45.

Prognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases.

Nishioka Y, Moriyama J, Matoba S, Kuroyanagi H, Hashimoto M, Shindoh J.

Dig Surg. 2018;35(3):187-195. doi: 10.1159/000478791. Epub 2017 Aug 19.

46.

Fluorine-18-fluorodeoxyglucose positron emission tomography as an objective substitute for CT morphologic response criteria in patients undergoing chemotherapy for colorectal liver metastases.

Nishioka Y, Yoshioka R, Gonoi W, Sugawara T, Yoshida S, Hashimoto M, Shindoh J.

Abdom Radiol (NY). 2018 May;43(5):1152-1158. doi: 10.1007/s00261-017-1287-0.

PMID:
28815337
47.

Tunable High-Pressure Field Operating on a Cationic Biphenyl Derivative Intercalated in Clay Minerals.

Tominaga M, Nishioka Y, Tani S, Suzuki Y, Kawamata J.

Sci Rep. 2017 Aug 9;7(1):7651. doi: 10.1038/s41598-017-08064-0.

48.

Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer.

Shigematsu Y, Oue N, Nishioka Y, Sakamoto N, Sentani K, Sekino Y, Mukai S, Teishima J, Matsubara A, Yasui W.

Oncol Lett. 2017 Jul;14(1):999-1004. doi: 10.3892/ol.2017.6230. Epub 2017 May 23.

49.

Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas.

Kaneko MK, Kunita A, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Ogasawara S, Ohishi T, Abe S, Itai S, Harada H, Kawada M, Nishioka Y, Fukayama M, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2017 Aug;36(4):157-162. doi: 10.1089/mab.2017.0020. Epub 2017 Jun 30.

PMID:
28665782
50.

Thymidine Catabolism as a Metabolic Strategy for Cancer Survival.

Tabata S, Yamamoto M, Goto H, Hirayama A, Ohishi M, Kuramoto T, Mitsuhashi A, Ikeda R, Haraguchi M, Kawahara K, Shinsato Y, Minami K, Saijo A, Hanibuchi M, Nishioka Y, Sone S, Esumi H, Tomita M, Soga T, Furukawa T, Akiyama SI.

Cell Rep. 2017 May 16;19(7):1313-1321. doi: 10.1016/j.celrep.2017.04.061.

Supplemental Content

Loading ...
Support Center